| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.004 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.097 | 0.005 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.091 | 0.007 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.38 | 0.007 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.088 | 0.007 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.36 | 0.007 |